Behind ALNY's Big Move: Frontier Pact Adds Genetic Drug Optionality
ALNY has announced a pivotal partnership with Frontier Pact, enhancing its genetic drug offerings. This could significantly impact ALNY's market trajectory.
Latest news and analysis for Alnylam Pharmaceuticals (ALNY).
ALNY has announced a pivotal partnership with Frontier Pact, enhancing its genetic drug offerings. This could significantly impact ALNY's market trajectory.
Bank of America has revised its price target for Alnylam Pharmaceuticals to $462. What does this mean for ALNY investors?